C12N 2770/32641
Use of virus, viral particle or viral elements as a vector
C12N2770/32641 (Use of virus, viral particle or viral elements as a vector) appears on 27 US grants and 18 published applications in this corpus.
Search patents in C12N- Granted patents
- 27
- Published applications
- 18
- Assignees
- 12
- Inventors
- 57
- Latest grant
- 28 Jun 2011
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 1 |
| 2002 | 4 | 3 |
| 2003 | 1 | 6 |
| 2004 | 4 | 2 |
| 2005 | 0 | 2 |
| 2006 | 2 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/32643Viral genome or elements thereof as genetic vectorIndexing code25
- C12N 2770/32644Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code2
- C12N 2770/32642Virus or viral particle as vehicleIndexing code0
- C12N 2770/32645Special targeting system for viral vectorsIndexing code0
Recent patents
- Genetically stable enterovirus expression vector with replaced stem loop VI28 Jun 2011US 7,968,086 B2Duke University
- Bacterial vectors and methods of use thereof24 Jun 2008US 7,390,646 B2The Regents of the University of California
- Recombinant viral nucleic acids20 Mar 2007US 7,192,740 B2Large Scale Biology Corporation
- Recombinant poliovirus for the treatment of cancer12 Dec 2006US 7,147,848 B2The Research Foundation of State University of New York
- Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP)21 Nov 2006US 7,138,274 B2Creagene Inc.
- Rna vectors with hairpin-like inserts17 Sep 2026US 2026/0275366 A1
- Methods for determining tumor immune status6 Jun 2024US 2024/0180984 A1Duke University
- Cationic nanoparticles for enhancing infectious capacity of live viruses27 Feb 2020US 2020/0060981 A1
- Novel recombinant sabin type 1 poliovirus vector and vaccine against poliovirus2 Mar 2006US 2006/0045889 A1Creagene Inc.
- Cytoplasmic inhibition of gene expression15 Sep 2005US 2005/0204422 A1Large Scale Biology Corporation
Most cited
By later US patents
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Recombinant plant viral nucleic acids105US 5,589,367 ABiosource Technologies, Inc. · 1996
- Recombinant plant viral nucleic acids86US 5,866,785 ABiosource Technologies, Inc. · 1999
- Recombinant plant viral nucleic acids73US 5,889,190 ABiosource Technologies, Inc. · 1999
- Bacterial vectors and methods of use thereof52US 7,390,646 B2The Regents of the University of California · 2008